January 17, 2017 12:39 PM ET

Healthcare Equipment and Supplies

Company Overview of Solta Medical, Inc.

Company Overview

Solta Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system, a treatment to improve skin texture and help prevent the signs of aging skin. The company also provides Thermage CPT system that provides non-invasive treatment options...

25881 Industrial Boulevard

Hayward, CA 94545

United States

Founded in 1996

371 Employees





Key Executives for Solta Medical, Inc.

Chief Executive Officer, President and Director
Age: 57
Corporate Controller
Age: 52
Treasurer and Director
Age: 54
Secretary and Director
Age: 46
Vice President of Global Sales
Compensation as of Fiscal Year 2016.

Solta Medical, Inc. Key Developments

Valeant Reportedly Works With Morgan Stanley To Sell Solta Medical And Obagi Medical

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has engaged Morgan Stanley for the sale of Obagi Medical Products, Inc. and Solta Medical, Inc. to raise cash to reduce debt, according to people familiar with the matter. The two sale could fetch as much as $500 million and the sale process could start as early as this week, the people added. Bloomberg added that representatives at Valeant and Morgan Stanley declined to comment.

Solta Medical, Inc. Launches Clear + Brilliant Pelo Laser

Solta Medical, Inc. announced the availability of the Clear + Brilliant pelo laser in the United States, a sophisticated approach to permanent hair reduction. The launch of this device, which joins the comprehensive portfolio of Solta Medical's aesthetic device solutions, follows a unique partnership with German Medical Engineering. The Clear + Brilliant pelo laser system uses a novel linear scanning approach with integrated contact cooling to deliver the effectiveness of current best-in-class diode laser hair removal technology with the fast and large treatment area available (50 mm by 15 mm). In addition, a unique all-inclusive subscription model will provide ease-of-mind and simplicity in ensuring consistent device performance and dependable support. Clear + Brilliant pelo will first be made exclusively available to current Solta Medical customers in the U.S, with full release scheduled in the fourth quarter of 2015.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Solta Medical, Inc., please visit www.solta.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.